The MEK1/2 inhibitor U0126 significantly reduced ERK1/2 and p90RSK1 phosphorylation, although changes in p90RSK1 phosphorylation were generally modest as CLL cells appeared to have relatively high levels of basal phosphorylation in the absence of stimulation. This evidence concerns the gene MAPK3 and B-cell chronic lymphocytic leukemia.